5^th EORTC Quality of Life

Dear Colleagues,

It is our pleasure to invite you to the 5^th EORTC Quality of Life in Cancer Clinical Trials Conference which will be held in 2019. This event will give participants the opportunity to learn about the latest topics in quality of life (QOL) and patient reported outcomes research. The two-day conference aims to bring together over 30 of the world’s most influential QOL researchers. There will be presentations on current state-of-the-art methods for instrument development and QOL measurement in international cancer clinical trials, addressing a variety of topics from designing robust measures to understanding their clinical meaning. Discussions on new tools and emerging technologies that have the potential to change the way we measure QOL, as well as on the rapidly growing field of electronic questionnaire administration.

This event is meant to stimulate progress and ensure greater patient involvement in cancer clinical trials, hence, patients and patient advocates will be speaking and providing their unique vision on QOL. All academic attendees will be able to participate for free.

Finally, we would like to thank our sponsors, including the EORTC Quality of Life Group, for supporting this conference.

We are all looking forward to welcoming you to our conference and participating in an engaging exchange of ideas.
Dr. Andrew Bottomley (Conference Chair), and Drs. Jaap Reijneveld, Michael Koller, Henning Flechtner, Krzysztof Tomaszewski and Eva Greimel (Conference Co- Chairs)

Find the conference’s website here.